Carla Pettenati

1.9k total citations
27 papers, 1.1k citations indexed

About

Carla Pettenati is a scholar working on Physiology, Psychiatry and Mental health and Neurology. According to data from OpenAlex, Carla Pettenati has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 11 papers in Psychiatry and Mental health and 5 papers in Neurology. Recurrent topics in Carla Pettenati's work include Alzheimer's disease research and treatments (11 papers), Dementia and Cognitive Impairment Research (10 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Carla Pettenati is often cited by papers focused on Alzheimer's disease research and treatments (11 papers), Dementia and Cognitive Impairment Research (10 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Carla Pettenati collaborates with scholars based in Italy, United States and Canada. Carla Pettenati's co-authors include Carlo Caltagirone, Massimo Musicco, Katie Palmer, Alessandro Padovani, Fulvio Adorni, Antonio Russo, Roberta Perri, Federica Prinelli, Barbara Borroni and Simona Gabriella Di Santo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Neuropsychologia.

In The Last Decade

Carla Pettenati

26 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carla Pettenati Italy 15 487 446 214 185 134 27 1.1k
Marc L. Gordon United States 18 273 0.6× 358 0.8× 196 0.9× 135 0.7× 136 1.0× 41 1.1k
Les Shaw United States 10 434 0.9× 443 1.0× 157 0.7× 123 0.7× 135 1.0× 18 1.0k
Gerard Piñol‐Ripoll Spain 24 467 1.0× 320 0.7× 373 1.7× 177 1.0× 292 2.2× 88 1.7k
Hyun‐Sik Yang United States 20 674 1.4× 492 1.1× 313 1.5× 296 1.6× 150 1.1× 51 1.3k
Alessandro Salviati Italy 16 622 1.3× 411 0.9× 351 1.6× 235 1.3× 230 1.7× 45 1.3k
Margaret E. Flanagan United States 16 268 0.6× 212 0.5× 255 1.2× 151 0.8× 128 1.0× 60 935
N. P. L. G. Verhoeff Netherlands 18 411 0.8× 524 1.2× 217 1.0× 153 0.8× 208 1.6× 38 1.4k
Akinori Takeda Japan 18 512 1.1× 221 0.5× 237 1.1× 173 0.9× 107 0.8× 78 1.3k
Qi Qin China 14 347 0.7× 324 0.7× 277 1.3× 332 1.8× 55 0.4× 38 1.3k
Bradley B. Miller United States 12 464 1.0× 312 0.7× 206 1.0× 207 1.1× 121 0.9× 20 882

Countries citing papers authored by Carla Pettenati

Since Specialization
Citations

This map shows the geographic impact of Carla Pettenati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carla Pettenati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carla Pettenati more than expected).

Fields of papers citing papers by Carla Pettenati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carla Pettenati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carla Pettenati. The network helps show where Carla Pettenati may publish in the future.

Co-authorship network of co-authors of Carla Pettenati

This figure shows the co-authorship network connecting the top 25 collaborators of Carla Pettenati. A scholar is included among the top collaborators of Carla Pettenati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carla Pettenati. Carla Pettenati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bastiani, Luca, Loredana Fortunato, Fabrizio Bianchi, et al.. (2020). Rapid COVID-19 Screening Based on Self-Reported Symptoms: Psychometric Assessment and Validation of the EPICOVID19 Short Diagnostic Scale. Journal of Medical Internet Research. 23(1). e23897–e23897. 28 indexed citations
2.
Spalletta, Gianfranco, Vincenzo De Luca, Alessandro Padovani, et al.. (2013). Early onset versus late onset in Alzheimer’s disease: What is the reliable cut-off?. BOA (University of Milano-Bicocca). 2(1). 40–47. 11 indexed citations
3.
Musicco, Massimo, Fulvio Adorni, Simona Gabriella Di Santo, et al.. (2013). Inverse occurrence of cancer and Alzheimer disease. Neurology. 81(4). 322–328. 215 indexed citations
4.
Borroni, Barbara, Antonella Alberici, Mara Cercignani, et al.. (2011). Granulin mutation drives brain damage and reorganization from preclinical to symptomatic FTLD. Neurobiology of Aging. 33(10). 2506–2520. 78 indexed citations
5.
Musicco, Massimo, Katie Palmer, Antonio Russo, et al.. (2011). Association between Prescription of Conventional or Atypical Antipsychotic Drugs and Mortality in Older Persons with Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders. 31(3). 218–224. 34 indexed citations
6.
Serra, Laura, Roberta Perri, Lucia Fadda, et al.. (2010). Relationship between Cognitive Impairment and Behavioural Disturbances in Alzheimer’s Disease Patients. Behavioural Neurology. 23(3). 123–130. 10 indexed citations
7.
Spalletta, Gianfranco, Massimo Musicco, Alessandro Padovani, et al.. (2010). Neuropsychiatric Symptoms and Syndromes in a Large Cohort of Newly Diagnosed, Untreated Patients With Alzheimer Disease. American Journal of Geriatric Psychiatry. 18(11). 1026–1035. 154 indexed citations
8.
Musicco, Massimo, Katie Palmer, Giovanna Salamone, et al.. (2009). Predictors of progression of cognitive decline in Alzheimer’s disease: the role of vascular and sociodemographic factors. Journal of Neurology. 256(8). 1288–1295. 92 indexed citations
9.
Galimberti, Daniela, Chiara Fenoglio, Carlo Lovati, et al.. (2004). CCR2-64I polymorphism and CCR5Δ32 deletion in patients with Alzheimer's disease. Journal of the Neurological Sciences. 225(1-2). 79–83. 32 indexed citations
10.
Fenoglio, Chiara, Daniela Galimberti, Carlo Lovati, et al.. (2004). MCP-1 in Alzheimer’s disease patients: A-2518G polymorphism and serum levels. Neurobiology of Aging. 25(9). 1169–1173. 72 indexed citations
11.
Pettenati, Carla, Roberta Annicchiarico, & Carlo Caltagirone. (2003). Clinical pharmacology of anti‐Alzheimer drugs. Fundamental and Clinical Pharmacology. 17(6). 659–672. 13 indexed citations
12.
Perri, Roberta, Giovanni Augusto Carlesimo, Gian Daniele Zannino, et al.. (2003). Intentional and automatic measures of specific-category effect in the semantic impairment of patients with Alzheimer’s disease. Neuropsychologia. 41(11). 1509–1522. 39 indexed citations
13.
Borroni, Barbara, Carla Pettenati, Tania Bordonali, et al.. (2003). Serum cholesterol levels modulate long-term efficacy of cholinesterase inhibitors in Alzheimer disease. Neuroscience Letters. 343(3). 213–215. 23 indexed citations
14.
Padovani, Alessandro, Barbara Borroni, Francesca Colciaghi, et al.. (2002). Abnormalities in the Pattern of Platelet Amyloid Precursor Protein Forms in Patients With Mild Cognitive Impairment and Alzheimer Disease. Archives of Neurology. 59(1). 71–71. 81 indexed citations
15.
Borroni, Barbara, Francesca Colciaghi, Lucia Pastorino, et al.. (2001). Amyloid Precursor Protein in Platelets of Patients With Alzheimer Disease. Archives of Neurology. 58(3). 442–6. 67 indexed citations
16.
Mecocci, Patrizia, Judith Saxton, Luisa Bartorelli, et al.. (1999). Neuropsychological assessment of the severely impaired elderly patient: Validation of the Italian short version of the Severe Impairment Battery (SIB). Aging Clinical and Experimental Research. 11(4). 221–226. 15 indexed citations
17.
Musicco, Massimo, et al.. (1998). Mortality studies in the clarification of gene-environment interactions.. PubMed. 13(3). 253–6. 1 indexed citations
18.
Catania, Anna, Lorena Airaghi, Paola Motta, et al.. (1997). Cytokine Antagonists in Aged Subjects and Their Relation With Cellular Immunity. The Journals of Gerontology Series A. 52A(2). B93–B97. 68 indexed citations
19.
Meroni, Pier Luigi, F. Capsoni, María Orietta Borghi, et al.. (1992). Immunopharmacological activity of cefodizime in young and elderly subjects: In vitro and ex vivo studies. Infection. 20(S1). S61–S63. 6 indexed citations
20.
Galli, Massimo, et al.. (1986). Immunological Features of Nonhealing Midline Granuloma. ORL. 48(5). 256–260.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marc L. Gordon Breakdown of academic impact, for papers by Les Shaw Breakdown of academic impact, for papers by Gerard Piñol‐Ripoll Breakdown of academic impact, for papers by Hyun‐Sik Yang Breakdown of academic impact, for papers by Alessandro Salviati Breakdown of academic impact, for papers by Margaret E. Flanagan Breakdown of academic impact, for papers by N. P. L. G. Verhoeff Breakdown of academic impact, for papers by Akinori Takeda Breakdown of academic impact, for papers by Qi Qin Breakdown of academic impact, for papers by Bradley B. Miller
Rankless by CCL
2026